eGDR and gastrointestinal cancer mortality in the UK Biobank: a prospective cohort study
BACKGROUND: This study examined the associations of estimated glucose disposal rate (eGDR), a surrogate of insulin sensitivity, and the insulin resistance indices TG/HDL-C and TyG with gastrointestinal (GI) cancer mortality in the UK Biobank. METHODS: We included 369,447 participants without cancer at baseline and recorded 4,305 GI cancer-related deaths over a mean follow-up of 13.5 years. Fine-Gray models assessed associations of eGDR, TG/HDL-C, and TyG with GI cancer mortality. RESULTS: Higher eGDR was associated with lower pooled GI cancer mortality (sHR, 0.67; 95% CI, 0.61-0.74; P < 0.001); associations with EC, ESCC, CRC, LC, and PC mortality remained significant after false discovery rate (FDR) correction. TyG, but not TG/HDL-C, remained associated with pooled GI cancer mortality, and both markers remained associated with LC mortality. Subgroup analyses were exploratory. CONCLUSIONS: Higher eGDR was associated with lower pooled and several site-specific GI cancer mortality outcomes, whereas TG/HDL-C and TyG associations were modest and site-specific. These findings do not establish clinical utility.
Authors
- Jeanette Köppe (ORCID: https://orcid.org/0000-0003-3640-2995)
- René Thieme
- Chuang Yang (ORCID: https://orcid.org/0009-0009-6360-7698)
- I Gockel
- Patrick S. Plum
- Thomas Ebert
Institutions
- University of Basel (CH)
- Anhui Medical University (CN)
- University Children's Hospital Tübingen (DE)
- University Hospital Leipzig (DE)
- First Affiliated Hospital of Anhui Medical University (CN)
- Medizinische Universität Lausitz - Carl Thiem (DE)
Publication Details
- Journal
- BMC Cancer
- Published
- 2026-09-05
- DOI
- https://doi.org/10.1186/s12885-026-16931-1
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- European Foundation for the Study of Diabetes
- Deutsche Forschungsgemeinschaft
- Universität Leipzig